Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q1 EPS of ($0.25), $0.15 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.